se of Novel In-vitro Diagnostic Technologies [NAOR platform, Terasystem Breath Analyzer, VIRIONâ?¢ test and Voice Pattern test] and RT-PCR for rapid testing of SARS-CoV2 in Indian Population - Open Skies

Defence Research and Development Organisation DRDO0 个研究点目标入组 0 人开始时间: 待定最近更新: 2021年11月24日

研究概览

暂无简介。

•1. Asymptomatic or Symptomatic Male or Females with 18 years or more of age who are willing to provide informed consent or participation in this research and
•- who are approaching the research centre with or without suspected COVID 19 symptoms
•- who have been tested or intend to get tested for SARS COV 2 infection
•- patients with diagnosed COVID 19 infection
•- are healthy volunteers

•1. Participants who are unable to voluntarily consent for themselves or have a psychiatric history or dementia or mental retardation etc that impair judgement for participation
•2. Inability to undergo the research tests or methods including handling of smart phone applications
•3. Inability to submit to answer the required information on the CRF for social or psychological reasons
•4. Person under guardianship or protection of vulnerable adults
•5. Person deprived of liberty by a judicial or administrative decision

发起方

Defence Research and Development Organisation DRDO